SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001787604-19-000003
Filing Date
2019-09-13
Accepted
2019-09-13 14:59:39
Documents
2
Period of Report
2019-09-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_156840116304527.html 3  
1 FORM 3 wf-form3_156840116304527.xml 3 4754
2 POWER OF ATTORNEY, SANFILIPPO ex-24.htm EX-24 3173
  Complete submission text file 0001787604-19-000003.txt   9479
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O MELINTA THERAPEUTICS, INC. 44 WHIPPANY ROAD MORRISTOWN NJ 04960
Business Address
Sanfilippo Jennifer A (Reporting) CIK: 0001787604 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35405 | Film No.: 191092418